EssilorLuxottica stock
Price history
−41.44% over the period1 year: from €315.60 (November 17, 2025) to €184.80 (November 16, 2026), −41.44%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | €184.80 |
| October 30, 2026 | €184.30 |
| September 30, 2026 | €145.60 |
| August 31, 2026 | €160.35 |
| July 31, 2026 | €164.05 |
| June 30, 2026 | €164.05 |
| May 29, 2026 | €175.15 |
| April 30, 2026 | €181.25 |
| March 31, 2026 | €198.40 |
| February 27, 2026 | €225.20 |
| January 30, 2026 | €257.90 |
| December 31, 2025 | €269.90 |
| November 28, 2025 | €308.70 |
| November 17, 2025 | €315.60 |
At a glance
The company
Designs, manufactures, and distributes ophthalmic lenses, frames, sunglasses, and optical equipment and instruments globally
Latest results
Quarter to June 30, 2026 · EPS €3.37
TickerLandia's take on EssilorLuxottica
- Priced as usual relative to earnings: P/E on the latest fiscal year 37 vs a median of 35 over its last 9 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 34 vs 42 (−19%) in a group of 10.
- Strong point: Earnings stability (79/100 in its group). Weak point: Growth (41/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−42.38% from the 52-week high
Analysts · 23 analysts
Average target€215.91+16.84% vs. price
Buy 19 · Hold 3 · Sell 1
TickerLandia Fingerprint: EssilorLuxottica
Compared with similar companies: very high risk.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage43
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 34.1 42 Forward P/E 23.0 51 Price/sales 2.85 46 EV/EBITDA 16.7 54 Price/book 2.14 22 Profitabilityaverage44
How much it earns on revenue and capital.
Metric Value Position in group Net margin 8.5% 54 ROA 3.7% 34 Operating margin 12.8% 37 Gross margin 60.0% 63 ROE 6.7% 31 Earnings stabilityhigh79
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 0.6% 96 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthaverage41
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +5.17% 43 Earnings growth (year over year) +12.30% 35 Revenue growth (year over year) +5.70% 46 Financial strengthaverage42
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Debt/equitycounts in reverse: lower means more financial strength 0.38 44 Current ratio 0.89 10 Net debt/EBITDAcounts in reverse: lower means more financial strength 1.47 38 Interest coverage 11.1 75 Dividendhigh76
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years 27 years 71 Payout ratio 74.8% 81 Dividend yield 2.2% 76 Market momentumaverage49
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +15.11% 89 Relative strength (6 months) +2.37% 62 Distance from 200-day average +1.15% 43 1-year return −43.00% 2 Riskvery high85
How much the price swings.
Metric Value Position in group Beta (1 year) 1.02 73 Volatility (60 days) 42.0% 86 Maximum drawdown (12 months) 56.5% 97
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
EssilorLuxottica is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), EssilorLuxottica's P/E today is 37.1, in line with the median of its last 9 fiscal years (35.0; between 23.9 and 56.4 from 2016 to 2025). EssilorLuxottica's P/E (trailing 12 months): 34.1, −19% against the median of a group of 10 similar companies (41.9).
Compared with 10 similar companies
| Metric | EssilorLuxottica | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 34.1 | Low | |
| Forward P/E | 23.0 | Middle | |
| Operating margin | 12.8% | Low | |
| ROE | 6.7% | Low | |
| Debt/equity | 0.38 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: EssilorLuxottica. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
€14.82B
Latest quarter · Q2 2026
Net income
€1.57B
Latest quarter · Q2 2026
Quarterly net margin
10.6%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- €83.58B
- P/E
- 34.1
- EPS
- €5.35
- Volume
- 531.57K
- Daily trading
- €182.01M
- Dividend yield
- 2.16%
- Last ex-dividend on May 5, 2026
How EssilorLuxottica is changing
All resultsRevenue grew 14.6% a year on average over the last 5 years
Profits turn into cash: free cash flow equal to 150% of net income
Shares outstanding up 5.8% in 5 years
Returns
EssilorLuxottica returns with dividends
€1,000 invested in EssilorLuxottica 5 years ago, on November 16, 2021, would be worth €1,103 today with dividends reinvested: +10.30% in total, +1.98% per year. On price alone it would be €1,004 (+0.43%).
| Period | EssilorLuxottica | CAC 40 | €1,000 becomes |
|---|---|---|---|
| 1 month | +19.69% | +6.91% | €1,197 |
| 6 months | +6.67% | +5.24% | €1,067 |
| Year to date | −31.53% | +2.69% | €685 |
| 1 year | −40.08% | +3.08% | €599 |
| 3 years | +12.60% | +16.75% | €1,126 |
| 5 years | +10.30% | +17.01% | €1,103 |
| 10 years | +117.56% | +85.93% | €2,176 |
Over the last 6 months it has done better than 27% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. CAC 40: price only. Calculate your investment
The chart in detail
EssilorLuxottica: technical analysis
EssilorLuxottica shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 42.4% below its all-time closing high (€320.70, November 12, 2025).
- Trend
- No clear trend
- RSI (14 sessions)
- 60
- Between 30 and 70
- vs 200-session average
- +2.73%
Support and resistance
Price areas where EssilorLuxottica has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance€188.80+2.16%3 touches, last on June 15, 2026
- Last price€184.80
- Support€177.21−4.11%4 touches, last on August 6, 2026
- Support€161.52−12.60%5 touches, last on July 31, 2026
Volatility and risk
Over the last year it has moved roughly in line with the CAC 40.
- Beta (1 year) vs CAC 40
- 1.02
- Volatility (60 sessions, annualised)
- 42.0%
- Largest fall in the last year
- −55.96%
In session, November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
EssilorLuxottica: seasonality
Average monthly price change over 37 years
Over the last 37 years, the strongest month for EssilorLuxottica has been April: +3.16% on average, positive in 22 years out of 37. The weakest has been September: −0.75% on average, positive in 18 years out of 37. November, the current month, has been positive in 21 years out of 36 (+2.08% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.55% | −0.11% | 18 of 36 |
| February | +2.25% | +1.52% | 22 of 37 |
| March | +1.02% | +1.67% | 22 of 37 |
| April | +3.16% | +2.57% | 22 of 37 |
| May | −0.23% | −0.36% | 17 of 37 |
| June | +0.83% | +0.60% | 22 of 37 |
| July | +0.93% | +0.18% | 19 of 37 |
| August | −0.38% | −0.61% | 14 of 37 |
| September | −0.75% | 0.00% | 18 of 37 |
| October | +1.95% | +1.32% | 20 of 37 |
| November | +2.08% | +1.31% | 21 of 36 |
| December | +1.69% | +1.82% | 23 of 36 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
EssilorLuxottica and its competitors
Ray-Ban and Oakley sunglasses, Essilor and Varilux lenses, and the Stellest and Transitions lines are the names most people associate with EssilorLuxottica, a Paris-based group that designs, manufactures and distributes ophthalmic lenses, frames, sunglasses and eyecare instruments. Its brands also include Persol, Oliver Peoples, Costa, Nikon and Foster Grant eyewear, as well as SPECTRALIS and ANTERION imaging platforms and Satisloh finishing equipment.
- Headquarters
- Paris, France
- Employees
- 213,909
- Founded
- 1849
- Chief executive
- Francesco Milleri
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| EssilorLuxotticaEL | $92.38B | 12.8% | 34.1 | +6.67% |
| AlconALC | $35.16B | 12.9% | 56.3 | +23.96% |
| Sartorius Stedim BiotechDIM | $24B | 19.2% | 67.0 | +44.71% |
| Straumann HoldingSTMN | $20.43B | 24.7% | 46.5 | +30.89% |
| SartoriusSRT | $19.89B | 17.8% | 79.3 | +38.35% |
| ColoplastCOLO.B | $16.93B | 25.7% | 37.2 | +27.32% |
Same industry or related industries, similar size. Compare EssilorLuxottica with its competitors · Full profile
